Literature DB >> 8381977

Role of Na(+)-K(+)-ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide.

T Kanemura1, J Tamaoki, A Chiyotani, K Takeyama, N Sakai, E Tagaya, K Konno.   

Abstract

To elucidate the effects of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) on airway smooth muscle function, we studied rabbit isolated tracheal segments under isometric conditions in vitro. Addition of VIP and PACAP dose-dependently relaxed tracheal smooth muscle precontracted with acetylcholine, with the order potency being PACAP (1) > or = VIP (0.78), accompanied by the corresponding increase in intracellular cyclic AMP levels. The VIP- and PACAP-induced muscle relaxations were significantly inhibited by ouabain and K(+)-free medium. Incubation of tissues with VIP reduced the contractile responses to electrical field stimulation, whereas PACAP had no effect. These results suggest that VIP and PACAP may cause bronchodilation through activation of Na(+)-K(+)-ATPase and that VIP but not PACAP inhibits the release of acetylcholine from the cholinergic nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381977

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  5 in total

1.  Effects of vagal stimulation on slowly adapting pulmonary stretch receptors and lung mechanics in anesthetized rabbits.

Authors:  S Matsumoto
Journal:  Lung       Date:  1996       Impact factor: 2.584

2.  Stimulation of sodium pump by vasoactive intestinal peptide in guinea-pig isolated trachea: potential contribution to mechanisms underlying relaxation of smooth muscle.

Authors:  K J Morrison; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  Inhibition of bronchoconstriction by pituitary adenylate cyclase activating polypeptide (PACAP 1-27) in guinea-pigs in vivo.

Authors:  A Lindén; S Yoshihara; B Chan; J A Nadel
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

Review 4.  Airway smooth muscle relaxation.

Authors:  A J Knox; A E Tattersfield
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

5.  Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma.

Authors:  A Lindén; L Hansson; A Andersson; M Palmqvist; P Arvidsson; C-G Löfdahl; P Larsson; J Lötvall
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.